[Immobilized streptokinase (streptodecase) in the treatment of traumatic intra-ocular hemorrhage].
Streptodecase was used in experiments and in clinical practice for treatment of intraocular traumatic hemorrhages. The enzyme, at a dose of 30,000-45,000 .un, did not exhibit any toxico-allergic effects on eye tissues and caused maximal lysis of the blood clot. 114 patients were treated with the enzymatic preparation and in 60% of the patients blood, liberated into vitreous body, was completely lysed.
D000818:Animals; D004800:Enzymes, Immobilized / Q000008:administration & dosage / Q000627:therapeutic use*; D005128:Eye Diseases / Q000188:drug therapy* / Q000209:etiology; D005131:Eye Injuries / Q000150:complications*; D006470:Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D006988:Hyphema / Q000188:drug therapy / Q000209:etiology; D011817:Rabbits; D013300:Streptokinase / Q000008:administration & dosage / Q000627:therapeutic use*; D014822:Vitreous Body
D004800:Enzymes, Immobilized; D013300:Streptokinase
Immobilizovannaia streptokinaza (streptodekaza) v lechenii vnutriglaznykh krovoizliianiĭ travmaticheskogo geneza.